213 related articles for article (PubMed ID: 32351286)
1. Determining the role for uric acid in non-alcoholic steatohepatitis development and the utility of urate metabolites in diagnosis: An opinion review.
Brennan P; Clare K; George J; Dillon JF
World J Gastroenterol; 2020 Apr; 26(15):1683-1690. PubMed ID: 32351286
[TBL] [Abstract][Full Text] [Related]
2. Higher levels of serum uric acid influences hepatic damage in patients with non-alcoholic fatty liver disease (NAFLD).
Fernández Rodríguez CM; Aller R; Gutiérrez García ML; Ampuero J; Gómez-Camarero J; Martín-Mateos RMª; Burgos-Santamaría D; Rosales JM; Aspichueta P; Buque X; Latorre M; Andrade RJ; Hernández-Guerra M; Romero-Gómez M
Rev Esp Enferm Dig; 2019 Apr; 111(4):264-269. PubMed ID: 30810330
[TBL] [Abstract][Full Text] [Related]
3. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults.
Zheng X; Gong L; Luo R; Chen H; Peng B; Ren W; Wang Y
Lipids Health Dis; 2017 Oct; 16(1):202. PubMed ID: 29037239
[TBL] [Abstract][Full Text] [Related]
4. Higher Serum Uric Acid Level Predicts Non-alcoholic Fatty Liver Disease: A 4-Year Prospective Cohort Study.
Wei F; Li J; Chen C; Zhang K; Cao L; Wang X; Ma J; Feng S; Li WD
Front Endocrinol (Lausanne); 2020; 11():179. PubMed ID: 32328031
[No Abstract] [Full Text] [Related]
5. Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Jaruvongvanich V; Ahuja W; Wirunsawanya K; Wijarnpreecha K; Ungprasert P
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1031-1035. PubMed ID: 28639970
[TBL] [Abstract][Full Text] [Related]
6. The relationship of serum uric acid with non-alcoholic fatty liver disease.
Sertoglu E; Ercin CN; Celebi G; Gurel H; Kayadibi H; Genc H; Kara M; Dogru T
Clin Biochem; 2014 Apr; 47(6):383-8. PubMed ID: 24525254
[TBL] [Abstract][Full Text] [Related]
7. Can Serum Uric Acid Lowering Therapy Contribute to the Prevention or Treatment of Nonalcoholic Fatty Liver Disease?
Paschos P; Athyros VG; Tsimperidis A; Katsoula A; Grammatikos N; Giouleme O
Curr Vasc Pharmacol; 2018; 16(3):269-275. PubMed ID: 28676018
[TBL] [Abstract][Full Text] [Related]
8. Hyperuricemia is not associated with severity of liver fibrosis in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis.
Jaruvongvanich V; Ahuja W; Wijarnpreecha K; Ungprasert P
Eur J Gastroenterol Hepatol; 2017 Jun; 29(6):694-697. PubMed ID: 28252464
[TBL] [Abstract][Full Text] [Related]
9. Gender effect of hyperuricemia on the development of nonalcoholic fatty liver disease (NAFLD): A clinical analysis and mechanistic study.
Xu K; Zhao X; Fu X; Xu K; Li Z; Miao L; Li Y; Cai Z; Qiao L; Bao J
Biomed Pharmacother; 2019 Sep; 117():109158. PubMed ID: 31252266
[TBL] [Abstract][Full Text] [Related]
10. Hyperuricemia and nonalcoholic fatty liver disease: from bedside to bench and back.
Xu C
Hepatol Int; 2016 Mar; 10(2):286-93. PubMed ID: 26671825
[TBL] [Abstract][Full Text] [Related]
11. Hyperuricaemia and risk of nonalcoholic fatty liver disease: A meta-analysis.
Wijarnpreecha K; Panjawatanan P; Lekuthai N; Thongprayoon C; Cheungpasitporn W; Ungprasert P
Liver Int; 2017 Jun; 37(6):906-918. PubMed ID: 27891768
[TBL] [Abstract][Full Text] [Related]
12. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease.
Petta S; Cammà C; Cabibi D; Di Marco V; Craxì A
Aliment Pharmacol Ther; 2011 Oct; 34(7):757-66. PubMed ID: 21790685
[TBL] [Abstract][Full Text] [Related]
13. The xanthine oxidase inhibitor febuxostat suppresses development of nonalcoholic steatohepatitis in a rodent model.
Nakatsu Y; Seno Y; Kushiyama A; Sakoda H; Fujishiro M; Katasako A; Mori K; Matsunaga Y; Fukushima T; Kanaoka R; Yamamotoya T; Kamata H; Asano T
Am J Physiol Gastrointest Liver Physiol; 2015 Jul; 309(1):G42-51. PubMed ID: 25999428
[TBL] [Abstract][Full Text] [Related]
14. Hyperuricemia as an independent risk factor for non-alcoholic fatty liver disease (NAFLD) progression evaluated using controlled attenuation parameter-transient elastography: Lesson learnt from tertiary referral center.
Sandra S; Lesmana CRA; Purnamasari D; Kurniawan J; Gani RA
Diabetes Metab Syndr; 2019; 13(1):424-428. PubMed ID: 30641737
[TBL] [Abstract][Full Text] [Related]
15. Gender difference on the relationship between hyperuricemia and nonalcoholic fatty liver disease among Chinese: An observational study.
Yu XL; Shu L; Shen XM; Zhang XY; Zheng PF
Medicine (Baltimore); 2017 Sep; 96(39):e8164. PubMed ID: 28953666
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD): Current Concepts.
Papatheodoridi M; Cholongitas E
Curr Pharm Des; 2018; 24(38):4574-4586. PubMed ID: 30652642
[TBL] [Abstract][Full Text] [Related]
18. The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort.
Zelber-Sagi S; Ben-Assuli O; Rabinowich L; Goldstein A; Magid A; Shalev V; Shibolet O; Chodick G
Liver Int; 2015 Nov; 35(11):2408-15. PubMed ID: 25845417
[TBL] [Abstract][Full Text] [Related]
19. Association between Serum Uric Acid and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis.
Darmawan G; Hamijoyo L; Hasan I
Acta Med Indones; 2017 Apr; 49(2):136-147. PubMed ID: 28790228
[TBL] [Abstract][Full Text] [Related]
20. Response to The relationship between serum uric acid levels and NAFLD.
Zelber-Sagi S; Ben-Assuli O; Rabinowich L; Shalev V; Shibolet O; Chodick G
Liver Int; 2016 May; 36(5):769-70. PubMed ID: 26923311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
